Literature DB >> 16883122

Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis.

Anne-Cornélie J M de Pont1, Catherine S C Bouman, Kamran Bakhtiari, Marianne C L Schaap, Rienk Nieuwland, Augueste Sturk, Barbara A Hutten, Evert de Jonge, Margreeth B Vroom, Joost C M Meijers, Harry R Büller.   

Abstract

During continuous venovenous hemofiltration, predilution can prolong circuit survival time, but the underlying mechanism has not been elucidated. The aim of the present study was to compare predilution with postdilution, with respect to circuit thrombogenesis. Eight critically ill patients were treated with both predilutional and postdilutional continuous venovenous hemofiltration in a crossover fashion. A filtration flow of 60 ml/min was used in both modes. We chose blood flows of 140 and 200 ml/min during predilution and postdilution, respectively, to keep the total flow through the hemofilter constant. Extracorporeal circuit pressures were measured hourly, and samples of blood and ultrafiltrate were collected at five different time points. Thrombin-antithrombin complexes and prothrombin fragments F1 + 2 were measured by ELISA, and platelet activation was assessed by flow cytometry. No signs of thrombin generation or platelet activation were found during either mode. During postdilution, baseline platelet count and maximal prefilter pressure had a linear relation, whereas both parameters were inversely related with circuit survival time. In summary, predilution and postdilution did not differ with respect to extracorporeal circuit thrombogenesis. During postdilution, baseline platelet count and maximal prefilter pressure were inversely related with circuit survival time.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16883122     DOI: 10.1097/01.mat.0000227733.03278.5f

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  7 in total

1.  Effects of Baseline Thrombocytopenia and Platelet Decrease Following Renal Replacement Therapy Initiation in Patients With Severe Acute Kidney Injury.

Authors:  Benjamin R Griffin; Anna Jovanovich; Zhiying You; Paul Palevsky; Sarah Faubel; Diana Jalal
Journal:  Crit Care Med       Date:  2019-04       Impact factor: 7.598

Review 2.  Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.

Authors:  Yasushi Tsujimoto; Sho Miki; Hiroki Shimada; Hiraku Tsujimoto; Hideto Yasuda; Yuki Kataoka; Tomoko Fujii
Journal:  Cochrane Database Syst Rev       Date:  2021-09-14

3.  Timing of renal replacement therapy initiation for acute kidney injury.

Authors:  Alicia Isabel I Fayad; Daniel G Buamscha; Agustín Ciapponi
Journal:  Cochrane Database Syst Rev       Date:  2018-12-18

Review 4.  Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis.

Authors:  Matthew Brain; Elizabeth Winson; Owen Roodenburg; John McNeil
Journal:  BMC Nephrol       Date:  2017-02-20       Impact factor: 2.388

5.  Continuous Renal Replacement Therapy in Critically Ill Children.

Authors:  Demet Demirkol
Journal:  Turk Arch Pediatr       Date:  2022-09

Review 6.  Anticoagulant properties of drotrecogin alfa (activated) during hemofiltration in patients with severe sepsis.

Authors:  Anne C J M de Pont; Marcus J Schultz
Journal:  Crit Care       Date:  2009-02-02       Impact factor: 9.097

7.  Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study.

Authors:  Jimena del Castillo; Jesús López-Herce; Elena Cidoncha; Javier Urbano; Santiago Mencía; Maria J Santiago; Jose M Bellón
Journal:  Crit Care       Date:  2008-07-25       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.